Susquehanna International Group (Ireland)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,010
Closed -$1.11M 99
2023
Q4
$1.11M Sell
11,010
-818
-7% -$79K 0.25% 33
2023
Q3
$1.2M Buy
+11,828
New +$1.2M 0.28% 32

Other funds holding NVS

Susquehanna International Group (Ireland)'s NVS Position: Q1 2024 in Review

Susquehanna International Group (Ireland) sold out of Novartis (NVS) in Q1 2024, closing a stake of 11,010 shares — an estimated $1.11M sold.

Susquehanna International Group (Ireland) first reported a position in NVS in Q3 2023 and held it in 2 quarters. The position peaked at $1.2M in Q3 2023. 1,254 funds tracked by Wall St. Rank hold NVS as of Q1 2024.

  • Susquehanna International Group (Ireland) reported no remaining Novartis position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 11,010 Novartis shares in Q1 2024, an estimated $1.11M.
  • Susquehanna International Group (Ireland) first reported a position in Novartis in Q3 2023 and held it in 2 quarters.
  • Susquehanna International Group (Ireland)'s Novartis position peaked at $1.2M in Q3 2023.
  • 1,254 funds tracked by Wall St. Rank held Novartis as of Q1 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q1 2024, filed 7 May 2024.